Dublin, June 22, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Analysis and Forecast, 2017-2023 (Focus on Pacemakers Type Volume & Value, ICDs Type Volume & Value, Patent Landscape and 45 Country Analysis)" report to their offering.
The global pacemakers and ICDs market are expected to grow at a CAGR of 4.6% and 4.8% from 2017 to 2023.
The factors includes revenue growth by dual chamber ICDs and Leadless Pacemakers as well as MRI Compatible ICD devices. The pacemakers market by volume is expected to reach 1,433,358 units by 2023 and by value, it is anticipated to reach $10.19 billion. However, the ICDs market by volume is anticipated to grow over 392,267 units by 2023. The report is mainly focused on market volume and value for both pacemakers and ICDs in 45 countries across the globe.
Typically, Pacemakers pacemakers can be divided into single chamber, double chamber and biventricular pacemakers. On the other hand, ICDs can be classified as Single, Dual and Leadless & Others ICDs. The global market for single chamber pacemakers by volume was 496,959 in 2016 and is expected to grow at a CAGR of 1.3% during the forecast period from 2017 to 2023.
On the basis of end users, the market can be divided into hospitals, specialty clinics & cardiac centres, and ambulatory care centres. In geographical analysis both value and volume of approximately 45 countries have been considered. Asia is going to witness the highest growth in upcoming years due to huge patient base and government initiatives.
The market trend is slowly experiencing a paradigm shift from single chamber pacemakers to high end ICDs. The reason could be the benefits of ICDs over conventional pacemakers as the former is capable of both treating as well as preventing an abnormal heart beat. The key players in the global pacemakers and ICD market are Medtronic, BIOTRONIK, Inc., Boston Scientific Corporation, St. Jude Medical, ZOLL Medical Corporation, MEDICO S.p.A., and Pacetronix, among others.
Key Topics Covered:
Executive Summary
1 Report Scope and Methodology
2 Market Overview
2.1. Introduction
2.2. Need for Permanent Pacemakers and ICDs
2.3. Types of Pacemakers and ICDs
2.4. Components of Pacemakers & ICDs and their Differences
2.5. Difference between Pacemaker and ICD
2.6. Historical Trends
3 Market Dynamics
4 Pricing Trends
4.1. Overview
4.2. Pricing Trend Analysis
5 Competitive Landscape
5.1. Key Market Development Snapshot
5.1.1. Mergers and Acquisitions
5.1.2. Product Development & Launches
5.1.3. Business Expansions
5.2. Industry Attractiveness
6 Industry Insights
6.1. Regulatory Agencies
6.2. Patent Landscape
6.3. Legal Developments
6.3.1. Lawsuits
6.3.2. Innovations
6.3.3. Approvals
7 Global Pacemaker and ICDs Market, by Product Type
7.1. Pacemaker
7.1.1. Overview
7.1.2. Single Chamber Implantable Pacemakers
7.1.3. Dual Chamber Implantable Pacemakers
7.1.4. Biventricular Pacemakers and Others
7.1.4.1. External Pacemakers
7.2. Implantable Cardioverter Defibrillators (ICDs)
7.2.1. Overview
7.2.2. Single Chamber ICDs
7.2.3. Dual Chamber ICDs
7.2.4. Biventricular ICDs/CRT-DS and Others
7.2.4.1. Transvenous Implantable Cardioverter Defibrillators
7.2.4.2. Subcutaneous ICDs
8 Global Pacemakers and ICDs Market, By Applications (Qualitative Only)
8.1. Overview
8.2. Arrhythmia
8.3. Atrial Fibrillation
8.4. Heart Block
8.5. Long QT Syndrome
9 Global Pacemakers and ICDs Market, By End Users
9.1. Overview
9.2. Hospitals
9.3. Speciality Clinics & Cardiac Centres
9.4. Ambulatory centres
9.5. Others
10 Global Pacemakers and ICDs Market, By Region
11 Company Profiles
- Asahi Kasei Corp.
- BIOTRONIK SE & Co. KG
- Boston Scientific
- EBR Systems, Inc.
- MEDICO S.p.A.
- Medtronic Inc.
- Nihon Kohden Corp.
- Osypka Medical GmbH
- Physio-Control Corp.
- Shree Pacetronix Ltd.
- St. Jude Medical, Inc
- ZOLL Medical Corp.
For more information about this report visit https://www.researchandmarkets.com/research/tn6dkw/global_pacemakers